ORGANIC
LETTERS
1999
Vol. 1, No. 7
1129-1132
Synthesis and Structure of
Tolyporphin A O,O-Diacetate
Wengui Wang and Yoshito Kishi*
Department of Chemistry and Chemical Biology, HarVard UniVersity,
12 Oxford Street, Cambridge, Massachusetts 02138
Received August 18, 1999
ABSTRACT
The revised structure of tolyporphin A O,O-diacetate (2b) was synthesized by assembling fragments 4, 5, and 12. The synthetic substance was
found to be identical to the O,O-diacetate derived from natural tolyporphin A in every respect, thus establishing the relative and absolute
configurations of this natural product.
In 1992, Moore and co-workers reported the isolation of
tolyporphin A from the lipophilic extract of the cyanophyte
microalga Tolypothrix nodosa. This structurally unique
porphyrin was found to reverse multidrug resistance (MDR)1
in a vinblastine-resistant population of human ovarian
adenocarcinoma cells.2a Subsequently, 10 additional toly-
porphins (B-K) were isolated and were found to possess
varying degrees of anti-MDR activity.2b-d On the basis of
extensive spectroscopic studies, the structure of tolyporphin
A, the representative member of the tolyporphin class of
natural products, was concluded to be 1a.2a We previously
described a total synthesis of the proposed structure of (+)-
tolyporphin A O,O-diacetate (1b) but found that the synthetic
material was not identical to the O,O-diacetate derived from
Subsequently, we carried out extensive spectroscopic
natural (+)-tolyporphin A.3
studies on both the synthetic material and the O,O-diacetate
derived from natural tolyporphin A and proposed the revised
(1) For recent reviews on MDR, see: (a) Pastan, I.; Gottesman, M. M.
structure 2a for tolyporphin A.4 In this Letter, we report a
Annu. ReV. Biochem. 1993, 62, 385. (b) Simon, S. M.; Schindler, M. Proc.
total synthesis of the O,O-diacetate 2b of the revised structure
of tolyporphin A, unambiguously establishing the relative
and absolute configurations of this natural product.5
Natl. Acad. Sci. U.S.A. 1994, 91, 3497.
(2) (a) Prinsep, M. R.; Caplan, F. R.; Moore, R. E.; Patterson, G. M. L.;
Smith, C. D. J. Am. Chem. Soc. 1992, 114, 385. (b) Prinsep, M. R.;
Patterson, G. M. L.; Larsen, L. K.; Smith, C. D. Tetrahedron 1995, 51,
10523. (c) Prinsep, M. R.; Patterson, G. M. L.; Larsen, L. K.; Smith, C. D.
J. Nat. Prod. 1998, 61, 1133. (d) Morliere, P.; Maziere, J.-C.; Santus, R.;
Smith, C. D.; Prinsep, M. R.; Stobbe, C. C.; Fenning, M. C.; Golberg, J.
L.; Chapman, J. D. Cancer Res. 1998, 58, 3571.
(3) Minehan, T. G.; Kishi, Y. Angew. Chem. Int. Ed. 1999, 38, 923.
(4) Minehan, T. G.; Cook-Blumberg, L.; Kishi, Y.; Prinsep, M. R.;
Moore, R. E. Angew. Chem. Int. Ed. 1999, 38, 926.
10.1021/ol9902374 CCC: $18.00 © 1999 American Chemical Society
Published on Web 09/09/1999